Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Other 1Genitourinary 1

Conditions

Stomatitis 1Sarcoma 1Neoplasms 1Mucositis 1Kidney Diseases 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Sodium Bicarbonate × Clear all
NCT00540904 2014-03-03

Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

Barretos Cancer Hospital

Phase 2 Completed
27 enrolled
Genitourinary

Kidney Diseases

NCT00965172 2012-03-22

Caphosol in Sarcoma Patients With Mucositis

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled
OtherSarcoma

Neoplasms, Sarcoma, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡